Dr. Manoj Agarwal, CEO of Kairos Pharma, shares insights on the company’s oncology pipeline and development strategy. On Pipeline Priorities...
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2025 earnings results today. Reported sales increased 9.1% year-over-year to $24.56 billion. Operational sales growth was…
Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Wednesday reported a double-digit growth in revenues for the fourth quarter of fiscal 2025. Total…
Marc Belsky, CEO of Plus Therapeutics, discusses advances in radiopharmaceutical treatments for cancer. On Technology Q: Can you explain Plus...
Kimball Carr, CEO of Inspire Veterinary Partners, discusses the veterinary practice consolidation opportunity and the company’s growth strategy. On Industry...
Daniel Wagner, CEO of Rezolve Ai, discusses how artificial intelligence is transforming commerce experiences. On AI Applications Q: How is...
Paul Romness, CEO of OS Therapies, discusses the company’s commitment to developing treatments for osteosarcoma. On Unmet Need Q: Why...
Zheng Zhong, CEO of Richtech Robotics, discusses the growing adoption of service robots across industries. On Market Trends Q: What...
Lewis Bender, CEO of Intensity Therapeutics, discusses the company’s intratumoral drug delivery approach. On Technology Platform Q: Can you explain...
Dr. Ben Hwang, CEO of Profusa, discusses the future of continuous health monitoring through implantable biosensors. On Technology Vision Q:...
